» Articles » PMID: 9009303

Characterization, Occurrence, and Molecular Cloning of a 39-kilodalton Brucella Abortus Cytoplasmic Protein Immunodominant in Cattle

Overview
Journal Infect Immun
Date 1997 Feb 1
PMID 9009303
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

Monoclonal antibodies and polyclonal antisera recognizing a 39-kDa protein (P39) of brucellin, a cytoplasmic extract from Brucella melitensis rough strain B115, were produced. The P39 was purified by anion-exchange chromatography. Eleven of fourteen Brucella-infected cows whose infections had been detected by the delayed-type hypersensitivity (DTH) test with brucellergen also developed a DTH reaction when purified P39 was used as the trigger. The T-cell proliferative responses to P39 of peripheral blood lymphocytes from Brucella-infected cows were also positive. None of the animals infected with other bacterial species that are presumed to induce immunological cross-reactions with Brucella spp. reacted to P39, either in DTH tests or in lymphocyte proliferation assays. A lambda gt11 genomic library of Brucella abortus was screened with a monoclonal antibody specific for P39, and the gene coding for this protein was subsequently isolated. The nucleotide sequence of the P39 gene was determined, and the deduced amino acid sequence is in accordance with the sequence of an internal peptide isolated from P39.

Citing Articles

Molecular host-pathogen interaction in brucellosis: current understanding and future approaches to vaccine development for mice and humans.

Ko J, Splitter G Clin Microbiol Rev. 2003; 16(1):65-78.

PMID: 12525425 PMC: 145300. DOI: 10.1128/CMR.16.1.65-78.2003.


Yersinia enterocolitica as a vehicle for a naked DNA vaccine encoding Brucella abortus bacterioferritin or P39 antigen.

Al-Mariri A, Tibor A, Lestrate P, Mertens P, De Bolle X, Letesson J Infect Immun. 2002; 70(4):1915-23.

PMID: 11895955 PMC: 127831. DOI: 10.1128/IAI.70.4.1915-1923.2002.


Brucella abortus genes identified following constitutive growth and macrophage infection.

Eskra L, Canavessi A, Carey M, Splitter G Infect Immun. 2001; 69(12):7736-42.

PMID: 11705955 PMC: 98869. DOI: 10.1128/IAI.69.12.7736-7742.2001.


Induction of immune response in BALB/c mice with a DNA vaccine encoding bacterioferritin or P39 of Brucella spp.

Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godfroid J Infect Immun. 2001; 69(10):6264-70.

PMID: 11553569 PMC: 98760. DOI: 10.1128/IAI.69.10.6264-6270.2001.


Protection of BALB/c mice against Brucella abortus 544 challenge by vaccination with bacterioferritin or P39 recombinant proteins with CpG oligodeoxynucleotides as adjuvant.

Al-Mariri A, Tibor A, Mertens P, De Bolle X, Michel P, Godefroid J Infect Immun. 2001; 69(8):4816-22.

PMID: 11447155 PMC: 98569. DOI: 10.1128/IAI.69.8.4816-4822.2001.


References
1.
ELBERG S . Immunity to brucella infection. Medicine (Baltimore). 1973; 52(4):339-56. DOI: 10.1097/00005792-197307000-00013. View

2.
Bhongbhibhat N, ELBERG S, Chen T . Characterization of brucella skin-test antigens. J Infect Dis. 1970; 122(1):70-82. DOI: 10.1093/infdis/122.1-2.70. View

3.
Nakane P, Kawaoi A . Peroxidase-labeled antibody. A new method of conjugation. J Histochem Cytochem. 1974; 22(12):1084-91. DOI: 10.1177/22.12.1084. View

4.
SANGER F, Nicklen S, Coulson A . DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A. 1977; 74(12):5463-7. PMC: 431765. DOI: 10.1073/pnas.74.12.5463. View

5.
Cannat A, Bousquet C, Serre A . Response of high and low antibody producer to Brucella. Ann Immunol (Paris). 1978; 129 C(5):669-83. View